nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—OPRL1—forebrain—attention deficit hyperactivity disorder	0.0362	0.121	CbGeAlD
Buprenorphine—OPRL1—nervous system—attention deficit hyperactivity disorder	0.0196	0.0655	CbGeAlD
Buprenorphine—OPRL1—central nervous system—attention deficit hyperactivity disorder	0.0189	0.0631	CbGeAlD
Buprenorphine—OPRD1—forebrain—attention deficit hyperactivity disorder	0.0186	0.0621	CbGeAlD
Buprenorphine—OPRK1—forebrain—attention deficit hyperactivity disorder	0.0179	0.0596	CbGeAlD
Buprenorphine—OPRL1—brain—attention deficit hyperactivity disorder	0.015	0.0501	CbGeAlD
Buprenorphine—OPRM1—forebrain—attention deficit hyperactivity disorder	0.0127	0.0424	CbGeAlD
Buprenorphine—OPRD1—nervous system—attention deficit hyperactivity disorder	0.0101	0.0337	CbGeAlD
Buprenorphine—OPRD1—central nervous system—attention deficit hyperactivity disorder	0.00974	0.0325	CbGeAlD
Buprenorphine—OPRK1—nervous system—attention deficit hyperactivity disorder	0.0097	0.0323	CbGeAlD
Buprenorphine—OPRK1—central nervous system—attention deficit hyperactivity disorder	0.00934	0.0311	CbGeAlD
Buprenorphine—OPRK1—cerebellum—attention deficit hyperactivity disorder	0.00913	0.0304	CbGeAlD
Buprenorphine—OPRM1—midbrain—attention deficit hyperactivity disorder	0.00839	0.028	CbGeAlD
Buprenorphine—OPRD1—brain—attention deficit hyperactivity disorder	0.00773	0.0258	CbGeAlD
Buprenorphine—OPRK1—brain—attention deficit hyperactivity disorder	0.00741	0.0247	CbGeAlD
Buprenorphine—CYP2A6—cerebellum—attention deficit hyperactivity disorder	0.00696	0.0232	CbGeAlD
Buprenorphine—OPRM1—nervous system—attention deficit hyperactivity disorder	0.0069	0.023	CbGeAlD
Buprenorphine—OPRM1—central nervous system—attention deficit hyperactivity disorder	0.00664	0.0222	CbGeAlD
Buprenorphine—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.00574	0.0191	CbGeAlD
Buprenorphine—CYP2A6—brain—attention deficit hyperactivity disorder	0.00565	0.0188	CbGeAlD
Buprenorphine—OPRM1—brain—attention deficit hyperactivity disorder	0.00527	0.0176	CbGeAlD
Buprenorphine—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.0051	0.017	CbGeAlD
Buprenorphine—ABCG2—midbrain—attention deficit hyperactivity disorder	0.00491	0.0164	CbGeAlD
Buprenorphine—ABCG2—cerebellum—attention deficit hyperactivity disorder	0.0038	0.0127	CbGeAlD
Buprenorphine—ABCB1—forebrain—attention deficit hyperactivity disorder	0.00367	0.0122	CbGeAlD
Buprenorphine—CYP2C8—brain—attention deficit hyperactivity disorder	0.00317	0.0106	CbGeAlD
Buprenorphine—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.0031	0.0103	CbGeAlD
Buprenorphine—ABCG2—brain—attention deficit hyperactivity disorder	0.00308	0.0103	CbGeAlD
Buprenorphine—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00281	0.00937	CbGeAlD
Buprenorphine—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.00277	0.00923	CbGeAlD
Buprenorphine—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00271	0.00903	CbGeAlD
Buprenorphine—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.00266	0.00888	CbGeAlD
Buprenorphine—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.0026	0.00868	CbGeAlD
Buprenorphine—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00242	0.00807	CbGeAlD
Buprenorphine—CYP2D6—brain—attention deficit hyperactivity disorder	0.00211	0.00705	CbGeAlD
Buprenorphine—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00199	0.00664	CbGeAlD
Buprenorphine—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.00192	0.00639	CbGeAlD
Buprenorphine—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.00187	0.00624	CbGeAlD
Buprenorphine—ABCB1—brain—attention deficit hyperactivity disorder	0.00152	0.00507	CbGeAlD
Buprenorphine—CYP2C18—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000775	0.00111	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000765	0.00109	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000755	0.00108	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00075	0.00107	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000748	0.00107	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000747	0.00107	CbGpPWpGaD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000734	0.00105	CbGpPWpGaD
Buprenorphine—CYP2C19—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000704	0.00101	CbGpPWpGaD
Buprenorphine—CYP2C19—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000699	0.000998	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000695	0.000993	CbGpPWpGaD
Buprenorphine—CYP2C19—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000694	0.000992	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00069	0.000985	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000681	0.000973	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000679	0.00097	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000676	0.000965	CbGpPWpGaD
Buprenorphine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.000676	0.000965	CbGpPWpGaD
Buprenorphine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.000676	0.000965	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000673	0.000962	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000662	0.000946	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000662	0.000945	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000662	0.000945	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000656	0.000937	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000654	0.000934	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000649	0.000927	CbGpPWpGaD
Buprenorphine—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000648	0.000925	CbGpPWpGaD
Buprenorphine—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000643	0.000918	CbGpPWpGaD
Buprenorphine—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000642	0.000917	CbGpPWpGaD
Buprenorphine—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000639	0.000912	CbGpPWpGaD
Buprenorphine—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000637	0.00091	CbGpPWpGaD
Buprenorphine—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000634	0.000906	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000634	0.000906	CbGpPWpGaD
Buprenorphine—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000633	0.000904	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000631	0.000902	CbGpPWpGaD
Buprenorphine—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	0.000619	0.000885	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000613	0.000875	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000611	0.000873	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00061	0.000871	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000609	0.00087	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000605	0.000865	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000601	0.000858	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000595	0.00085	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000594	0.000848	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000593	0.000846	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00059	0.000843	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000583	0.000833	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000581	0.000829	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00058	0.000829	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000576	0.000822	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000573	0.000819	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000569	0.000813	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000559	0.000799	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000554	0.000791	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000554	0.000791	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000553	0.00079	CbGpPWpGaD
Buprenorphine—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000549	0.000783	CbGpPWpGaD
Buprenorphine—ABCG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000546	0.000779	CbGpPWpGaD
Buprenorphine—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000545	0.000778	CbGpPWpGaD
Buprenorphine—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000541	0.000773	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000536	0.000766	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000536	0.000765	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000535	0.000764	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000535	0.000764	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000534	0.000763	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000527	0.000753	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000526	0.000752	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00052	0.000743	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00052	0.000742	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000515	0.000736	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000515	0.000736	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000503	0.000719	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000501	0.000715	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000499	0.000713	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000491	0.000701	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00049	0.0007	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000489	0.000699	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000485	0.000692	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000484	0.000692	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000481	0.000687	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000472	0.000674	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000468	0.000668	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000459	0.000655	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000453	0.000647	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000451	0.000644	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000445	0.000636	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00044	0.000628	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000428	0.000611	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000426	0.000609	CbGpPWpGaD
Buprenorphine—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000423	0.000605	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000423	0.000604	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000423	0.000604	CbGpPWpGaD
Buprenorphine—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00042	0.0006	CbGpPWpGaD
Buprenorphine—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000418	0.000596	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000416	0.000594	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00041	0.000585	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000407	0.000581	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000402	0.000575	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000401	0.000573	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000387	0.000553	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000387	0.000552	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000374	0.000534	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000373	0.000533	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000372	0.000532	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000361	0.000516	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000359	0.000512	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000359	0.000512	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000356	0.000508	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000356	0.000508	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000355	0.000507	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000353	0.000504	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000352	0.000502	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000351	0.000501	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00035	0.0005	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00034	0.000486	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00034	0.000485	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000338	0.000483	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000328	0.000469	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000327	0.000467	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000327	0.000467	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000326	0.000466	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000326	0.000466	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000325	0.000464	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—COMT—attention deficit hyperactivity disorder	0.000324	0.000463	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000323	0.000461	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000322	0.00046	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000322	0.00046	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000321	0.000458	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000317	0.000452	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000316	0.000451	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000311	0.000445	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000307	0.000439	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000298	0.000426	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000297	0.000425	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000295	0.000421	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000288	0.000411	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000287	0.00041	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000287	0.00041	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000286	0.000409	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000284	0.000406	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000284	0.000406	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000281	0.000401	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000276	0.000395	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000273	0.00039	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000271	0.000387	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000271	0.000387	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000268	0.000382	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000265	0.000378	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000263	0.000376	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000263	0.000375	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000261	0.000372	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00026	0.000371	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000257	0.000367	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000257	0.000367	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—COMT—attention deficit hyperactivity disorder	0.000256	0.000366	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000254	0.000363	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000253	0.000361	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000248	0.000354	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000247	0.000352	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000242	0.000346	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000235	0.000336	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000229	0.000327	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000224	0.00032	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000223	0.000318	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000223	0.000318	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000219	0.000313	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000217	0.00031	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000216	0.000308	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—COMT—attention deficit hyperactivity disorder	0.000215	0.000308	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000214	0.000306	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000205	0.000293	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000204	0.000291	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000201	0.000287	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000199	0.000284	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000199	0.000284	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000197	0.000282	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000196	0.00028	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000196	0.000279	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000195	0.000279	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000194	0.000277	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000194	0.000277	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000191	0.000273	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000183	0.000261	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000183	0.000261	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000182	0.00026	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000181	0.000259	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000181	0.000259	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00018	0.000257	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000178	0.000255	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000178	0.000254	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000177	0.000253	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000173	0.000247	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00017	0.000242	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000169	0.000242	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000167	0.000239	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000166	0.000237	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000159	0.000227	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—COMT—attention deficit hyperactivity disorder	0.000156	0.000222	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000155	0.000221	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000155	0.000221	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000155	0.000221	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000155	0.000221	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000152	0.000218	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000151	0.000216	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000148	0.000211	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000146	0.000209	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000145	0.000207	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000142	0.000202	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000139	0.000199	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—EP300—attention deficit hyperactivity disorder	0.000139	0.000198	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000138	0.000197	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—COMT—attention deficit hyperactivity disorder	0.000135	0.000193	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000134	0.000191	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.00013	0.000186	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000124	0.000177	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000121	0.000173	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	0.00012	0.000172	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00012	0.000171	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000119	0.000171	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000119	0.000171	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000118	0.000168	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000118	0.000168	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000118	0.000168	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000117	0.000167	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000116	0.000166	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000111	0.000158	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00011	0.000157	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—EP300—attention deficit hyperactivity disorder	0.00011	0.000157	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	0.00011	0.000157	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000109	0.000156	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000109	0.000156	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000106	0.000152	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000106	0.000151	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.55e-05	0.000136	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	9.38e-05	0.000134	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—EP300—attention deficit hyperactivity disorder	9.32e-05	0.000133	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	9.31e-05	0.000133	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—EP300—attention deficit hyperactivity disorder	9.24e-05	0.000132	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.09e-05	0.00013	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	9.03e-05	0.000129	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.98e-05	0.000128	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—EP300—attention deficit hyperactivity disorder	8.47e-05	0.000121	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	7.24e-05	0.000103	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	7.19e-05	0.000103	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—EP300—attention deficit hyperactivity disorder	6.68e-05	9.54e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—EP300—attention deficit hyperactivity disorder	5.78e-05	8.26e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	5.16e-05	7.37e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	5.04e-05	7.2e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	4.75e-05	6.78e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	4.71e-05	6.72e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	4.02e-05	5.75e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	3.1e-05	4.43e-05	CbGpPWpGaD
